Latest Kaiser Health News Stories
Funding for CHIP technically expired Oct. 1. Although both Democrats and Republicans said they wanted to continue the program, they could not agree on how to fund it.
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
In this episode of “What The Health?” — taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss possible new work requirements for Medicaid recipients and the latest on renewing the Children’s Health Insurance Program, plus Rovner interviews Princeton health historian Paul Starr.
Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.
In a short-term spending bill, Congress extends money to the Children’s Health Insurance Program through March.
The House sought to eliminate the tax deduction, generally used by people with serious illnesses or those who need long-term care services but it was eventually restored in the final bill — and expanded.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss this week’s news, including health issues in the just-passed tax bill and a look back on the year in health policy.
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
Funding for the joint federal-state Children’s Health Insurance Program expired Oct. 1, and Congress has not yet agreed to a plan to continue the popular coverage.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss health issues in the emerging tax bill, including the likely repeal of fines for those who fail to obtain health insurance. They also talk about the end of “open enrollment” for 2018 individual health insurance coverage.
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Congress let funding for the Children’s Health Insurance Program expire in September, and despite bipartisan support for the program, states are facing the specter of having to prepare to wind down their programs.
The sticking point is not whether to keep the popular Children’s Health Insurance Program running but how best to raise the cash.
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
About 9 million people claimed about $87 billion in medical deductions in 2015.